KAYLA KEIPER: Open Payments
NPI 1114536893 · GREENSBURG, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,612 in 111 payments from 11 companies in 2025. Trend: 2023 $313 · 2024 $1,372 · 2025 $1,612
Food & beverage: $1,612
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 46 | $420 |
| Alkermes, Inc. | 16 | $288 |
| Vanda Pharmaceuticals Inc. | 14 | $230 |
| Otsuka America Pharmaceutical, Inc. | 10 | $160 |
| Teva Pharmaceuticals USA, Inc. | 6 | $145 |
| Neurocrine BioSciences, Inc. | 5 | $98 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $90 |
| Janssen Pharmaceuticals, Inc | 4 | $82 |
| Lundbeck LLC | 3 | $51 |
| Collegium Pharmaceutical, Inc. | 2 | $34 |
Products named: VRAYLAR, ARISTADA, REXULTI, FANAPT, AUSTEDO XR, INGREZZA, CAPLYTA, HETLIOZ.
Industry payments across PA — which companies pay providers there.
